Lee DM, Weinblatt ME: Rheumatoid arthritis. Lancet. 2001, 358: 903-911. 10.1016/S0140-6736(01)06075-5.
Article
CAS
PubMed
Google Scholar
Scott DL, Wolfe F, Huizinga TW: Rheumatoid arthritis. Lancet. 2010, 376: 1094-1108. 10.1016/S0140-6736(10)60826-4.
Article
PubMed
Google Scholar
McInnes IB, Schett G: The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011, 365: 2205-2219. 10.1056/NEJMra1004965.
Article
CAS
PubMed
Google Scholar
Klareskog L, Catrina AI, Paget S: Rheumatoid arthritis. Lancet. 2009, 373: 659-672. 10.1016/S0140-6736(09)60008-8.
Article
CAS
PubMed
Google Scholar
McInnes IB, Schett G: Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007, 7: 429-442. 10.1038/nri2094.
Article
CAS
PubMed
Google Scholar
Karmakar S, Kay J, Gravallese EM: Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention. Rheum Dis Clin North Am. 2010, 36: 385-404. 10.1016/j.rdc.2010.03.003.
Article
PubMed
PubMed Central
Google Scholar
van Vollenhoven RF: New and future agents in the treatment of rheumatoid arthritis. Discov Med. 2010, 9: 319-327.
PubMed
Google Scholar
Lipsky PE: Are new agents needed to treat RA?. Nat Rev Rheumatol. 2009, 5: 521-522. 10.1038/nrrheum.2009.197.
Article
PubMed
Google Scholar
Gotzsche PC: Non-steroidal anti-inflammatory drugs. Clin Evid. 2002, 1063-1070.
Google Scholar
O’Shea JJ, Laurence A, McInnes IB: Back to the future: oral targeted therapy for RA and other autoimmune diseases. Nat Rev Rheumatol. 2013, 9: 173-182. 10.1038/nrrheum.2013.7.
Article
PubMed
PubMed Central
Google Scholar
van Vollenhoven RF: Rheumatoid arthritis in 2012: Progress in RA genetics, pathology and therapy. Nat Rev Rheumatol. 2013, 9: 70-72. 10.1038/nrrheum.2012.232.
Article
CAS
PubMed
Google Scholar
Cutolo M: The kinase inhibitor tofacitinib in patients with rheumatoid arthritis: latest findings and clinical potential. Ther Adv Musculoskelet Dis. 2013, 5: 3-11. 10.1177/1759720X12470753.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zwerina J, Redlich K, Schett G, Smolen JS: Pathogenesis of rheumatoid arthritis: targeting cytokines. Ann N Y Acad Sci. 2005, 1051: 716-729. 10.1196/annals.1361.116.
Article
CAS
PubMed
Google Scholar
van den Berg WB: Anti-cytokine therapy in chronic destructive arthritis. Arthritis Res. 2001, 3: 18-26. 10.1186/ar136.
Article
CAS
PubMed
Google Scholar
Choy EH, Panayi GS: Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 2001, 344: 907-916. 10.1056/NEJM200103223441207.
Article
CAS
PubMed
Google Scholar
Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, Burdick MD, Pope RM, Strieter RM: Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest. 1992, 90: 772-779. 10.1172/JCI115950.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vervoordeldonk MJ, Tak PP: Cytokines in rheumatoid arthritis. Curr Rheumatol Rep. 2002, 4: 208-217. 10.1007/s11926-002-0067-0.
Article
PubMed
Google Scholar
Choi Y, Arron JR, Townsend MJ: Promising bone-related therapeutic targets for rheumatoid arthritis. Nat Rev Rheumatol. 2009, 5: 543-548. 10.1038/nrrheum.2009.175.
Article
CAS
PubMed
PubMed Central
Google Scholar
Feldmann M, Brennan FM, Elliott MJ, Williams RO, Maini RN: TNF alpha is an effective therapeutic target for rheumatoid arthritis. Ann N Y Acad Sci. 1995, 766: 272-278. 10.1111/j.1749-6632.1995.tb26675.x.
Article
CAS
PubMed
Google Scholar
Maini RN, Elliott M, Brennan FM, Williams RO, Feldmann M: Targeting TNF alpha for the therapy of rheumatoid arthritis. Clin Exp Rheumatol. 1994, 12 (Suppl 11): S63-S66.
PubMed
Google Scholar
Isaacs JD: Therapeutic agents for patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor-alpha antagonists. Expert Opin Biol Ther. 2009, 9: 1463-1475. 10.1517/14712590903379494.
Article
CAS
PubMed
Google Scholar
Ebert EC, Das KM, Mehta V, Rezac C: Non-response to infliximab may be due to innate neutralizing anti-tumour necrosis factor-alpha antibodies. Clin Exp Immunol. 2008, 154: 325-331. 10.1111/j.1365-2249.2008.03773.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bingham B, Ajit SK, Blake DR, Samad TA: The molecular basis of pain and its clinical implications in rheumatology. Nat Clin Pract Rheumatol. 2009, 5: 28-37. 10.1038/ncprheum0972.
Article
CAS
PubMed
Google Scholar
Zhang JM, An J: Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007, 45: 27-37. 10.1097/AIA.0b013e318034194e.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hendiani JA, Westlund KN, Lawand N, Goel N, Lisse J, McNearney T: Mechanical sensation and pain thresholds in patients with chronic arthropathies. J Pain. 2003, 4: 203-211. 10.1016/S1526-5900(03)00557-1.
Article
PubMed
Google Scholar
Stucky CL, Gold MS, Zhang X: Mechanisms of pain. Proc Natl Acad Sci U S A. 2001, 98: 11845-11846. 10.1073/pnas.211373398.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lee YC, Cui J, Lu B, Frits ML, Iannaccone CK, Shadick NA, Weinblatt ME, Solomon DH: Pain persists in DAS28 rheumatoid arthritis remission but not in ACR/EULAR remission: a longitudinal observational study. Arthritis Res Ther. 2011, 13: R83-10.1186/ar3353.
Article
PubMed
PubMed Central
Google Scholar
Pincus T: The American College of Rheumatology (ACR) Core Data Set and derivative “patient only” indices to assess rheumatoid arthritis. Clin Exp Rheumatol. 2005, 23: S109-S113.
CAS
PubMed
Google Scholar
Heiberg T, Kvien TK: Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority. Arthritis Rheum. 2002, 47: 391-397. 10.1002/art.10515.
Article
PubMed
Google Scholar
Hegen M, Keith JC, Collins M, Nickerson-Nutter CL: Utility of animal models for identification of potential therapeutics for rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 1505-1515. 10.1136/ard.2007.076430.
Article
CAS
PubMed
Google Scholar
Williams RO, Feldmann M, Maini RN: Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A. 1992, 89: 9784-9788. 10.1073/pnas.89.20.9784.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nishimoto N, Kishimoto T, Yoshizaki K: Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis. 2000, 59 (Suppl 1): i21-i27.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kollias G, Papadaki P, Apparailly F, Vervoordeldonk MJ, Holmdahl R, Baumans V, Desaintes C, Di Santo J, Distler J, Garside P, Hegen M, Huizinga WJT, Jüngel A, Klareskog L, McInnes I, Ragoussis I, Schett G, Hart B, Tak PP, Toes R, van den Berg W, Wurst W, Gay S: Animal models for arthritis: innovative tools for prevention and treatment. Ann Rheum Dis. 2011, 70: 1357-1362. 10.1136/ard.2010.148551.
Article
PubMed
Google Scholar
Bolon B, Stolina M, King C, Middleton S, Gasser J, Zack D, Feige U: Rodent preclinical models for developing novel antiarthritic molecules: comparative biology and preferred methods for evaluating efficacy. J Biomed Biotechnol. 2011, 2011: 569068-
Article
PubMed
Google Scholar
Kannan K, Ortmann RA, Kimpel D: Animal models of rheumatoid arthritis and their relevance to human disease. Pathophysiology. 2005, 12: 167-181. 10.1016/j.pathophys.2005.07.011.
Article
PubMed
Google Scholar
Cromartie WJ, Craddock JG, Schwab JH, Anderle SK, Yang CH: Arthritis in rats after systemic injection of streptococcal cells or cell walls. J Exp Med. 1977, 146: 1585-1602. 10.1084/jem.146.6.1585.
Article
CAS
PubMed
Google Scholar
Schwab JH, Anderle SK, Brown RR, Dalldorf FG, Thompson RC: Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infect Immun. 1991, 59: 4436-4442.
CAS
PubMed
PubMed Central
Google Scholar
Bevaart L, Vervoordeldonk MJ, Tak PP: Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis?. Arthritis Rheum. 2010, 62: 2192-2205. 10.1002/art.27503.
Article
CAS
PubMed
Google Scholar
Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 1994, 53: 55-63. 10.1016/0165-0270(94)90144-9.
Article
CAS
PubMed
Google Scholar
Boettger MK, Hensellek S, Richter F, Gajda M, Stockigt R, von Banchet GS, Brauer R, Schaible HG: Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum. 2008, 58: 2368-2378. 10.1002/art.23608.
Article
CAS
PubMed
Google Scholar
Boettger MK, Weber K, Schmidt M, Gajda M, Brauer R, Schaible HG: Gait abnormalities differentially indicate pain or structural joint damage in monoarticular antigen-induced arthritis. Pain. 2009, 145: 142-150. 10.1016/j.pain.2009.06.006.
Article
PubMed
Google Scholar
Buchner E, Brauer R, Schmidt C, Emmrich F, Kinne RW: Induction of flare-up reactions in rat antigen-induced arthritis. J Autoimmun. 1995, 8: 61-74.
CAS
PubMed
Google Scholar
Sternberg EM, Hill JM, Chrousos GP, Kamilaris T, Listwak SJ, Gold PW, Wilder RL: Inflammatory mediator-induced hypothalamic-pituitary-adrenal axis activation is defective in streptococcal cell wall arthritis-susceptible Lewis rats. Proc Natl Acad Sci U S A. 1989, 86: 2374-2378. 10.1073/pnas.86.7.2374.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gross S, Gammon ST, Moss BL, Rauch D, Harding J, Heinecke JW, Ratner L, Piwnica-Worms D: Bioluminescence imaging of myeloperoxidase activity in vivo. Nat Med. 2009, 15: 455-461. 10.1038/nm.1886.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tseng JC, Kung AL: In vivo imaging of inflammatory phagocytes. Chem Biol. 2012, 19: 1199-1209. 10.1016/j.chembiol.2012.08.007.
Article
CAS
PubMed
Google Scholar
Schimmer RC, Schrier DJ, Flory CM, Laemont KD, Tung D, Metz AL, Friedl HP, Conroy MC, Warren JS, Beck B, Ward PA: Streptococcal cell wall-induced arthritis: requirements for IL-4, IL-10, IFN-gamma, and monocyte chemoattractant protein-1. J Immunol. 1998, 160: 1466-1471.
CAS
PubMed
Google Scholar
Schaible HG, Ebersberger A, von Banchet GS: Mechanisms of pain in arthritis. Ann N Y Acad Sci. 2002, 966: 343-354. 10.1111/j.1749-6632.2002.tb04234.x.
Article
CAS
PubMed
Google Scholar
Esser RE, Stimpson SA, Cromartie WJ, Schwab JH: Reactivation of streptococcal cell wall-induced arthritis by homologous and heterologous cell wall polymers. Arthritis Rheum. 1985, 28: 1402-1411. 10.1002/art.1780281213.
Article
CAS
PubMed
Google Scholar
Schimmer RC, Schrier DJ, Flory CM, Dykens J, Tung DK, Jacobson PB, Friedl HP, Conroy MC, Schimmer BB, Ward PA: Streptococcal cell wall-induced arthritis. Requirements for neutrophils, P-selectin, intercellular adhesion molecule-1, and macrophage-inflammatory protein-2. J Immunol. 1997, 159: 4103-4108.
CAS
PubMed
Google Scholar
Rioja I, Clayton CL, Graham SJ, Life PF, Dickson MC: Gene expression profiles in the rat streptococcal cell wall-induced arthritis model identified using microarray analysis. Arthritis Res Ther. 2005, 7: R101-R117. 10.1186/ar1458.
Article
CAS
PubMed
Google Scholar
Rioja I, Bush KA, Buckton JB, Dickson MC, Life PF: Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin Exp Immunol. 2004, 137: 65-73. 10.1111/j.1365-2249.2004.02499.x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Woolf CJ, Salter MW: Neuronal plasticity: increasing the gain in pain. Science. 2000, 288: 1765-1769. 10.1126/science.288.5472.1765.
Article
CAS
PubMed
Google Scholar
Denko CW, Petricevic M: Sympathetic or reflex footpad swelling due to crystal-induced inflammation in the opposite foot. Inflammation. 1978, 3: 81-86. 10.1007/BF00917323.
Article
CAS
PubMed
Google Scholar
Inglis JJ, Notley CA, Essex D, Wilson AW, Feldmann M, Anand P, Williams R: Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum. 2007, 56: 4015-4023. 10.1002/art.23063.
Article
PubMed
Google Scholar
Setoguchi C, Tsuji F, Katsuta O, Okamoto M, Aono H: Combined effects of bucillamine and etanercept on a rat type II collagen-induced arthritis model. Mod Rheumatol. 2010, 20: 381-388. 10.3109/s10165-010-0292-8.
Article
CAS
PubMed
Google Scholar
Bendele A: Animal models of rheumatoid arthritis. J Musculoskelet Neuronal Interact. 2001, 1: 377-385.
CAS
PubMed
Google Scholar
Christoph T, Kogel B, Schiene K, Meen M, De Vry J, Friderichs E: Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain. Eur J Pharmacol. 2005, 507: 87-98. 10.1016/j.ejphar.2004.11.052.
Article
CAS
PubMed
Google Scholar
van Schouwenburg PA, Rispens T, Wolbink GJ: Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis. Nat Rev Rheumatol. 2013, 9: 164-172. 10.1038/nrrheum.2013.4.
Article
CAS
PubMed
Google Scholar
Green M: Nonclinical Pharmacology and Toxicology Review of BLA 98–0286. 1998, Ref Type: Report (Web URL: http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm088697.pdf
Google Scholar
Jamnitski A, Krieckaert CL, Nurmohamed MT, Hart MH, Dijkmans BA, Aarden L, Voskuyl AE, Wolbink GJ: Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients. Ann Rheum Dis. 2012, 71: 88-91.
Article
CAS
PubMed
Google Scholar
LoBuglio AF, Wheeler RH, Trang J, Haynes A, Rogers K, Harvey EB, Sun L, Ghrayeb J, Khazaeli MB: Mouse/human chimeric monoclonal antibody in man: kinetics and immune response. Proc Natl Acad Sci U S A. 1989, 86: 4220-4224. 10.1073/pnas.86.11.4220.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wolbink GJ, Vis M, Lems W, Voskuyl AE, de Groot E, Nurmohamed MT, Stapel S, Tak PP, Aarden L, Dijkmans B: Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis. Arthritis Rheum. 2006, 54: 711-715. 10.1002/art.21671.
Article
PubMed
Google Scholar
Haraoui B, Cameron L, Ouellet M, White B: Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response. J Rheumatol. 2006, 33: 31-36.
CAS
PubMed
Google Scholar
Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, Antoni C, Leeb B, Elliott MJ, Woody JN, Schaible TF, Feldmann M: Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 1998, 41: 1552-1563. 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W.
Article
CAS
PubMed
Google Scholar